LATIKAFUSP

UNII:	F188ZI78F7
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	LATIKAFUSP
GSRS Full Record:	F188ZI78F7 i

2552814-07-8
IMMUNOGLOBULIN G1 (296-CYSTEINE,301-GLYCINE,306-CYSTEINE,360-LYSINE,403-LYSINE,DE-451-LYSINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL 22D4.017XIL21R9ER76A .GAMMA.1-CHAIN) FUSION PROTEIN WITH INTERLEUKIN 21 (9-GLUTAMIC ACID,76-ALANINE) (HUMAN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL 22D4.017XIL21R9ER76A .LAMBDA.-CHAIN, (230->230'),(233->233')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (296-CYSTEINE,301-GLYCINE,306-CYSTEINE,396-ASPARTIC ACID,413-ASPARTIC ACID) ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL 22D4.017XIL21R9ER76A .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL 22D4.017XIL21R9ER76A .LAMBDA.-CHAIN
Latikafusp [WHO-DD]
latikafusp [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LATIKAFUSP

Synonyms and Mappings

Resources